Health Care Reform

Deloitte Center for Health Solutions

The U.S. health care system is complex, fragmented and expensive. Some might say it is not a system at all; rather, it is a collection of organizations that provide goods and services for individual patients and groups, under the scrutiny of industry watchdogs.

The cost of the U.S. health care system is projected to increase at 5.8 percent annually through 2020. Health care is the fastest-growing expense in the average American household, in the overhead of employers who provide health insurance, and in state and federal government budgets. Not surprisingly, new entrants offering “lower-cost, better solutions” are now focused on the health care industry: They regard it as a prime target for disruptive innovation. Reforming the U.S. health care system is a fiscal imperative. Reducing its costs while enhancing the quality of its goods and services is its greatest challenge.

More Featured insights

HR’s growing role in delivering health reform
The recent book from Deloitte LLP on employer health care reform discusses how decade-old assumptions about employer-based health care are crumbling and HR professionals now have a chance to shape it to the company’s advantage.
2012 Outlook on health care, life sciences and government
Deloitte LLP's Paul Keckley, Ph.D., executive director of the Deloitte Center for Health Solutions, and John Bigalke, vice chairman and U.S. national industry leader, Health Sciences & Government, share their outlook on the year ahead.
The fiscal impact to states of the Affordable Care Act (ACA): Comprehensive analysis
Deloitte constructed plausible scenarios to identify cost/saving drivers and provide a range of the estimated per-person fiscal impact to states due to ACA requirements.
Monday Memo: Weekly Update on Health Care Reform
This weekly series highlights news from the previous week’s activities in the new administration, and reviews implications for the C-suite and various stakeholder groups. Stay up to date on Health Care Reform.
Transparency in life sciences
Watch our short video to learn ways life sciences companies are addressing the Sunshine Act and data concerns, new scrutiny for research and development (R&D) and stronger and more complex international enforcement.
Health reform and the individual insurance market
This Issue Brief offers a strategic assessment of the current and future individual insurance market that may assist states, health plans, and other stakeholders as they prepare for a dramatic uptick in enrollees and associated expectations.
Primary care: Today and tomorrow
With potentially 32 million newly insured seeking health care and a pending shortage of primary care physicians, this Issue Brief examines the challenges and barriers facing the U.S. health system.

Join our team

Explore Health Sciences career opportunities: Experienced Hires | Students

Stay updated

Subscribe to receive updates from Deloitte's Health Care practice:
CHS E-nail E-mail | Deloitte Health RSS RSS ( What is RSS?) | Twitter.com/deloittehealth Twitter

As used in this document, “Deloitte” means Deloitte LLP [and its subsidiaries]. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.